Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors

BACKGROUND: The success of cisplatin-based (Platinol, Bristol-Myers Squibb Company, New York, NY, USA) chemotherapy for testicular cancer comes at the price of long-term and late effects related to healthy tissue damage. We assessed and modelled serum platinum (Pt) decay after chemotherapy and deter...

Descripción completa

Detalles Bibliográficos
Autores principales: Boer, H., Proost, J. H., Nuver, J., Bunskoek, S., Gietema, J. Q., Geubels, B. M., Altena, R., Zwart, N., Oosting, S. F., Vonk, J. M., Lefrandt, J. D., Uges, D. R. A., Meijer, C., de Vries, E. G. E., Gietema, J. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621032/
https://www.ncbi.nlm.nih.gov/pubmed/26347114
http://dx.doi.org/10.1093/annonc/mdv369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621032/
https://www.ncbi.nlm.nih.gov/pubmed/26347114
http://dx.doi.org/10.1093/annonc/mdv369

Ejemplares similares